SOPH
SOPHiA GENETICS SA
+0.29 (+3.57%)8.26USD521K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 55 · 3.1M · 10 |
| 其中 10b5-1 計畫賣出 | 51 筆 |
| 近 180 天 買進 · 賣出金額 | 99K · 4.3M |
| 近 180 天 淨額 | −4.2M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | 09-17 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.0K | 7.88 | 32K | 553K | SEC |
| 2026-09-14 | 09-17 | Menu Philippe | Chief Medical Officer | S 公開市場賣出 | 5.0K | 7.88 | 39K | 208K | SEC |
| 2026-09-11 | 09-14 | Van Well Daan | Chief Legal Officer | S 公開市場賣出(10b5-1) | 6.2K | 7.63 | 47K | 339K | SEC |
| 2026-09-10 | 09-14 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 8.5K | 7.66 | 65K | 3.4M | SEC |
| 2026-09-08 | 09-10 | HIBBS KATHY L | Director | S 公開市場賣出(10b5-1) | 6.3K | 8.13 | 51K | 97.0K | SEC |
| 2026-08-27 | 08-31 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 10.0K | 8.91 | 89K | 557K | SEC |
| 2026-08-25 | 08-26 | HIBBS KATHY L | Director | S 公開市場賣出(10b5-1) | 6.3K | 8.68 | 54K | 103K | SEC |
| 2026-08-25 | 08-26 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 8.68 | 43K | 213K | SEC |
| 2026-08-24 | 08-26 | Verma Abhimanyu | Chief Technology Officer | S 公開市場賣出(10b5-1) | 5.0K | 8.80 | 44K | 172K | SEC |
| 2026-08-21 | 08-21 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.4K | 8.40 | 45K | 567K | SEC |
| 2026-08-20 | 08-21 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.6K | 8.41 | 39K | 572K | SEC |
| 2026-08-19 | 08-26 | Verma Abhimanyu | Chief Technology Officer | S 公開市場賣出(10b5-1) | 5.0K | 8.20 | 41K | 177K | SEC |
| 2026-08-19 | 08-21 | Valente Manuela | Chief People Officer | S 公開市場賣出(10b5-1) | 10.0K | 7.94 | 79K | 210K | SEC |
| 2026-08-19 | 08-21 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 10.0K | 7.94 | 79K | 577K | SEC |
| 2026-08-19 | 08-21 | Valente Manuela | Chief People Officer | M 選擇權執行 | 10.0K | 3.20 | 32K | 220K | SEC |
| 2026-08-13 | 08-14 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.0K | 7.52 | 30K | 587K | SEC |
| 2026-08-12 | 08-14 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 7.52 | 38K | 218K | SEC |
| 2026-08-10 | 08-10 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 8.5K | 7.61 | 65K | 3.4M | SEC |
| 2026-08-07 | 08-10 | Verma Abhimanyu | Chief Technology Officer | S 公開市場賣出(10b5-1) | 5.0K | 7.60 | 38K | 182K | SEC |
| 2026-08-07 | 08-10 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 20.0K | 7.23 | 145K | 3.5M | SEC |
| 2026-08-07 | 08-07 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 10.0K | 7.48 | 75K | 591K | SEC |
| 2026-08-07 | 08-07 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 7.0K | 7.02 | 49K | 601K | SEC |
| 2026-08-07 | 08-07 | Xu Zhenyu | Chief Scientific Officer | M 選擇權執行 | 7.0K | 3.28 | 23K | 608K | SEC |
| 2026-08-05 | 08-07 | Xu Zhenyu | Chief Scientific Officer | M 選擇權執行 | 3.0K | 3.28 | 10K | 604K | SEC |
| 2026-08-05 | 08-07 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 3.0K | 7.00 | 21K | 601K | SEC |
| 2026-08-04 | 08-05 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 20.0K | 6.92 | 138K | 3.5M | SEC |
| 2026-08-04 | 08-05 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 10.0K | 6.92 | 69K | 601K | SEC |
| 2026-08-04 | 08-05 | Verma Abhimanyu | Chief Technology Officer | S 公開市場賣出(10b5-1) | 5.0K | 6.95 | 35K | 187K | SEC |
| 2026-07-27 | 07-28 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 5.66 | 28K | 223K | SEC |
| 2026-07-21 | 07-22 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 20.0K | 6.63 | 133K | 3.5M | SEC |
| 2026-07-20 | 07-22 | Camblong Jurgi | Executive Chairman | M 選擇權執行 | 4.6K | 3.16 | 14K | 3.5M | SEC |
| 2026-07-20 | 07-22 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 19.8K | 6.32 | 125K | 3.5M | SEC |
| 2026-07-20 | 07-22 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 4.6K | 6.17 | 28K | 3.5M | SEC |
| 2026-07-13 | 07-14 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.0K | 5.70 | 23K | 611K | SEC |
| 2026-07-13 | 07-14 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 5.70 | 29K | 228K | SEC |
| 2026-07-10 | 07-14 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 8.5K | 5.62 | 48K | 3.5M | SEC |
| 2026-07-07 | 07-08 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 17.7K | 5.28 | 93K | 3.5M | SEC |
| 2026-07-06 | 07-07 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 22.5K | 5.26 | 118K | 3.6M | SEC |
| 2026-07-06 | 07-07 | Verma Abhimanyu | Chief Technology Officer | S 公開市場賣出(10b5-1) | 5.3K | 5.10 | 27K | 192K | SEC |
| 2026-07-06 | 07-07 | Valente Manuela | Chief People Officer | S 公開市場賣出(10b5-1) | 4.2K | 5.05 | 21K | 210K | SEC |
| 2026-07-06 | 07-07 | CARDOZA GEORGE | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.6K | 5.29 | 8K | 309K | SEC |
| 2026-07-06 | 07-07 | Muken Ross | Chief Executive Officer | S 公開市場賣出(10b5-1) | 9.8K | 5.22 | 51K | 671K | SEC |
| 2026-07-06 | 07-07 | Puylaert Kevin | Chief Sales Officer | S 公開市場賣出 | 31 | 5.09 | 157.67 | 148K | SEC |
| 2026-07-06 | 07-07 | Puylaert Kevin | Chief Sales Officer | S 公開市場賣出 | 47 | 5.03 | 236.18 | 148K | SEC |
| 2026-07-06 | 07-07 | Puylaert Kevin | Chief Sales Officer | S 公開市場賣出 | 138 | 5.03 | 693.46 | 148K | SEC |
| 2026-07-06 | 07-07 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 7.4K | 5.17 | 38K | 615K | SEC |
| 2026-07-06 | 07-07 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.4K | 5.16 | 38K | 233K | SEC |
| 2026-06-30 | 07-01 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 45.4K | 6.14 | 279K | 3.6M | SEC |
| 2026-06-30 | 07-01 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 19.6K | 6.02 | 118K | 3.6M | SEC |
| 2026-06-30 | 07-01 | Camblong Jurgi | Executive Chairman | M 選擇權執行 | 45.4K | 3.16 | 144K | 3.6M | SEC |
| 2026-06-30 | 07-01 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 200 | 6.30 | 1K | 3.6M | SEC |
| 2026-06-29 | 07-01 | Camblong Jurgi | Executive Chairman | M 選擇權執行 | 18.1K | 3.16 | 57K | 3.6M | SEC |
| 2026-06-29 | 07-01 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 350 | 6.00 | 2K | 3.6M | SEC |
| 2026-06-29 | 07-01 | Camblong Jurgi | Executive Chairman | S 公開市場賣出(10b5-1) | 18.1K | 5.87 | 106K | 3.6M | SEC |
| 2026-06-26 | 06-29 | Camblong Jurgi | Chief Executive Officer | S 公開市場賣出(10b5-1) | 18.1K | 5.73 | 104K | 3.6M | SEC |
| 2026-06-26 | 06-29 | Camblong Jurgi | Chief Executive Officer | S 公開市場賣出(10b5-1) | 31.9K | 5.84 | 187K | 3.6M | SEC |
| 2026-06-26 | 06-29 | Camblong Jurgi | Chief Executive Officer | M 選擇權執行 | 31.9K | 3.16 | 101K | 3.6M | SEC |
| 2026-06-25 | 06-29 | Camblong Jurgi | Chief Executive Officer | S 公開市場賣出(10b5-1) | 1.4K | 5.70 | 8K | 3.6M | SEC |
| 2026-06-25 | 06-26 | Verma Abhimanyu | Chief Technology Officer | S 公開市場賣出(10b5-1) | 6.9K | 5.51 | 38K | 197K | SEC |
| 2026-06-25 | 06-26 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 5.50 | 28K | 241K | SEC |
| 2026-06-22 | 06-23 | CARDOZA GEORGE | Chief Financial Officer | S 公開市場賣出(10b5-1) | 774 | 5.38 | 4K | 311K | SEC |
| 2026-06-22 | 06-23 | Muken Ross | President | S 公開市場賣出(10b5-1) | 422 | 5.38 | 2K | 680K | SEC |
| 2026-06-18 | 06-22 | Cossery Jean-Michel | Director | A 獲配股票 | 19.7K | 5.46 | 108K | 206K | SEC |
| 2026-06-18 | 06-22 | HIBBS KATHY L | Director | A 獲配股票 | 19.7K | 5.46 | 108K | 109K | SEC |
| 2026-06-18 | 06-22 | HIRSCH DIDIER | Director | A 獲配股票 | 19.7K | 5.46 | 108K | 240K | SEC |
| 2026-06-18 | 06-22 | Cox Troy | Director | A 獲配股票 | 19.7K | 5.46 | 108K | 329K | SEC |
| 2026-06-18 | 06-22 | Ossipow Vincent | Director | A 獲配股票 | 19.7K | 5.46 | 108K | 523K | SEC |
| 2026-06-15 | 06-17 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.0K | 5.01 | 20K | 622K | SEC |
| 2026-06-12 | 06-15 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 4.95 | 25K | 246K | SEC |
| 2026-06-10 | 06-11 | Camblong Jurgi | Chief Executive Officer | S 公開市場賣出(10b5-1) | 8.5K | 5.24 | 45K | 3.6M | SEC |
| 2026-06-05 | 06-05 | CARDOZA GEORGE | Chief Financial Officer | P 公開市場買進 | 20.0K | 4.95 | 99K | 311K | SEC |
| 2026-05-26 | 06-01 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.0K | 4.95 | 25K | 251K | SEC |
| 2026-05-19 | 05-20 | Valente Manuela | Chief People Officer | S 公開市場賣出(10b5-1) | 380 | 4.60 | 2K | 215K | SEC |
| 2026-05-19 | 05-20 | Muken Ross | President | S 公開市場賣出(10b5-1) | 761 | 4.60 | 4K | 681K | SEC |
| 2026-05-19 | 05-20 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 608 | 4.60 | 3K | 626K | SEC |
| 2026-05-19 | 05-20 | Camblong Jurgi | Chief Executive Officer | S 公開市場賣出(10b5-1) | 4.5K | 4.60 | 21K | 3.6M | SEC |
| 2026-05-19 | 05-20 | Menu Philippe | Chief Medical Officer | S 公開市場賣出(10b5-1) | 608 | 4.61 | 3K | 256K | SEC |
| 2026-05-19 | 05-20 | Van Well Daan | Chief Legal Officer | S 公開市場賣出(10b5-1) | 684 | 4.60 | 3K | 345K | SEC |
| 2026-05-19 | 05-20 | Puylaert Kevin | Chief Sales Officer | S 公開市場賣出 | 33 | 4.54 | 149.82 | 148K | SEC |
| 2026-05-13 | 05-14 | Xu Zhenyu | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.0K | 4.54 | 18K | 627K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 6.8M | 39.2M | 新進 | 新進 |
| AIGH Capital Management LLC | 4.0M | 22.8M | 新進 | 新進 |
| AKRE CAPITAL MANAGEMENT LLC | 3.7M | 21.5M | 新進 | 新進 |
| ROYCE & ASSOCIATES LP | 3.4M | 19.5M | 新進 | 新進 |
| PRINCIPAL FINANCIAL GROUP INC | 2.4M | 13.6M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 2.2M | 12.8M | 新進 | 新進 |
| BANQUE PICTET & CIE SA | 2.2M | 12.7M | 新進 | 新進 |
| AWM Investment Company, Inc. | 1.7M | 9.8M | 新進 | 新進 |
| Soleus Capital Management, L.P. | 1.6M | 9.0M | 新進 | 新進 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.4M | 8.2M | 新進 | 新進 |
| Alta Wealth Advisors LLC | 1.4M | 8.1M | 新進 | 新進 |
| KENNEDY CAPITAL MANAGEMENT LLC | 918K | 5.3M | 新進 | 新進 |
| Archon Capital Management LLC | 691K | 4.0M | 新進 | 新進 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 663K | 3.8M | 新進 | 新進 |
| Ensign Peak Advisors, Inc | 445K | 2.6M | 新進 | 新進 |
| Hodges Capital Management Inc. | 409K | 2.4M | 新進 | 新進 |
| Bank Pictet & Cie (Europe) AG | 255K | 1.5M | 新進 | 新進 |
| Legato Capital Management LLC | 223K | 1.3M | 新進 | 新進 |
| 1492 Capital Management LLC | 222K | 1.3M | 新進 | 新進 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 200K | 1.2M | 新進 | 新進 |
| SEI INVESTMENTS CO | 165K | 952K | 新進 | 新進 |
| Maven Securities LTD | 150K | 866K | 新進 | 新進 |
| FEDERATED HERMES, INC. | 142K | 819K | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 138K | 799K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 113K | 654K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 72 +23 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 72 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 36.8M |
| 合計季末市值 | 212M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.1M |
|---|---|
| 與上期比 | +18.5% |
| 佔流通股數 | –(外國發行人不算) |
| 日均成交量 | 576K |
| 回補天數 | 1.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.1M | +18.5% | – | 576K | 1.9 |
| 2026-08-14 | 931K | +21.1% | – | 558K | 1.7 |
| 2026-07-31 | 768K | +16.2% | – | 290K | 2.7 |
| 2026-07-15 | 661K | +4.0% | – | 314K | 2.1 |
| 2026-06-30 | 636K | +141.3% | – | 459K | 1.4 |
| 2026-06-15 | 264K | -5.5% | – | 141K | 1.9 |
| 2026-05-29 | 279K | +18.9% | – | 64.9K | 4.3 |
| 2026-05-15 | 235K | +18.3% | – | 119K | 2.0 |
| 2026-04-30 | 198K | +12.8% | – | 97.3K | 2.0 |
| 2026-04-15 | 176K | -31.0% | – | 93.0K | 1.9 |
| 2026-03-31 | 255K | +20.3% | – | 96.4K | 2.7 |
| 2026-03-13 | 212K | +16.0% | – | 126K | 1.7 |
| 2026-02-27 | 183K | -19.1% | – | 90.0K | 2.0 |
| 2026-02-13 | 226K | +194.3% | – | 258K | 1.0 |
| 2026-01-30 | 76.8K | +44.8% | – | 463K | 1.0 |
| 2026-01-15 | 53.0K | +68.3% | – | 137K | 1.0 |
| 2025-12-31 | 31.5K | -2.9% | – | 41.3K | 1.0 |
| 2025-12-15 | 32.4K | -26.5% | – | 99.2K | 1.0 |
| 2025-11-28 | 44.1K | -8.1% | – | 109K | 1.0 |
| 2025-11-14 | 48.0K | -65.1% | – | 93.3K | 1.0 |
| 2025-10-31 | 138K | +532.3% | – | 160K | 1.0 |
| 2025-10-15 | 21.8K | -34.4% | – | 104K | 1.0 |
| 2025-09-30 | 33.2K | +40.3% | – | 108K | 1.0 |
| 2025-09-15 | 23.7K | -45.5% | – | 34.5K | 1.0 |
| 2025-08-29 | 43.4K | +6.2% | – | 43.3K | 1.0 |
| 2025-08-15 | 40.9K | +122.3% | – | 142K | 1.0 |